DrugDev Hosts Webinars with Janssen, Baylor and CRBD+ to Discuss Best Practices for Becoming a High-Performing Site, and Pediatric Diabetes Research Collaboration

Share Article

InvestigatorView series of webinars provides an unfiltered forum for sites and medical leaders to share real-world experience that helps sponsors, CROs and sites to do more clinical trials together

InvestigatorView webinars are an unfiltered forum for sites and medical leaders to share real-world experience to help sponsors, CROs and sites to do more clinical trials together.

KING OF PRUSSIA, PA and LONDON, UK (PRWEB)November 10, 2015

DrugDev is pleased to host two new complimentary webinars in November and December as part of its educational InvestigatorView series, which provides an unfiltered forum to bring the often under-represented Investigator and Site view to a global virtual audience of health care professionals and industry professionals.

Abstract:
Are you a clinical research site that wants to be at the forefront of researching new treatments for your patients? Do you have the dedication, interest, passion and knowledge to conduct clinical trials? The role of the clinical research site is vital to developing new treatments for the patients who need them yet many sites are reluctant to get involved with clinical trials. In a survey of 750 Investigators representing 7 countries, physicians surveyed felt the greatest barriers to participation in clinical trials were the time demands, lack of resources and the complexity of running trials. This webinar will offer a frank discussion of the challenges, rewards and best practices of running clinical trials so you can determine your readiness and ability to succeed.

Presenter:
Matt Lowery, CCRC, Executive Director, CRBD+ – Over his 20+ year career Matt has held positions in corporate medical research offices, managed sites, and found his niche in business development and consulting. He is certified through ACRP and sits on one of TransCelerate’s site advocacy groups through the Society for Clinical Research Sites.

Abstract:
Since the Pediatric Research Equity Act (PREA 2003) and Best Pharmaceuticals for Children Act (BPCA 2002) there has been an increased need and focus on pediatric trials to ensure adequate testing for the safety and efficacy of new pediatric therapies. The goal is simple: test and develop new and innovative evidence-based medicines and therapies to extend and enhance the lives of children. Yet the challenges of running pediatric clinical trials are numerous, with concerns about inferior feasibility and declining clinician participation. This webinar will review the challenges of running pediatric trials from both the sponsor and site perspective and propose actionable solutions, particularly around the question as to whether collaboration is the key for future success in this area.

Presenters:
Dr. William Treem, Senior Director, Pediatric Drug Development, Janssen Pharmaceutical Research and Development – Dr. Treem is a trained pediatrician and pediatric gastroenterologist-hepatologist with a long career in academic pediatric gastroenterology as a clinician, clinical researcher, and teacher. He is a Senior Director of Pediatric Drug Development in the CHILD (Child Health Innovation and Leadership Department); Chairman of the Janssen Pediatric Center of Excellence; and co-chair of the Janssen Hepatic Safety Group

Maria Jose Redondo, MD, PhD, MPH, Associate Professor of Pediatrics, Pediatric Endocrinology and Metabolism, Texas Children's Hospital, Baylor College of Medicine – Dr. Maria J. Redondo's clinical and research activities focus on pediatric diabetes. She studies the genetic, immunologic and metabolic causes that lead to type 1 diabetes in children and offers prevention and treatment options. Dr. Redondo joined the Pediatric Diabetes and Endocrinology Center at Texas Children's Hospital/Baylor College of Medicine in 2010 where she is the Program Director and Principal Investigator for TrialNet, the T1D Exchange and the Pediatric Diabetes Consortium at Baylor. She has received awards from the Immunology of Diabetes Society, and the Juvenile Diabetes Research Foundation and has been elected a member of the Society for Pediatric Research. Dr. Redondo has published numerous articles on pediatric diabetes.

Moderator:
Both webinars will be moderated by Dr. Claire Sears, PhD, Director of Investigator Engagement at DrugDev. Dr. Sears emphasizes keeping an open line of communication with doctors. She firmly believes closer relationships between investigators, sites and industry can bring great benefits to the clinical trials process.

About DrugDev
DrugDev enables sponsors, CROs and sites to Do More Trials through industry-wide collaboration, standardization and a beautiful technology experience. Built around the largest global network of active opted-in investigators, DrugDev’s unified solutions suite optimizes site selection and startup, investigator payments and clinical operations. DrugDev also serves as the trusted third-party host of the revolutionary Investigator Databank collaboration and powers the TransCelerate Investigator Registry (launching this year). Learn why 9 of the top 10 sponsors and 4 of the top 5 CROs rely on DrugDev technology to do more trials at drugdev.com – and connect with DrugDev on LinkedIn and Twitter to join the conversation.